Isolation of a human serum protein that inhibits the growth of Cryptococcus neoformans

Mycopathologia

Volumn 144, Issue 1, 1998, Pages 1-7

  Duvvuru, Shanti ^a,b   Brummer, Elmer ^a,c,d   Morelli, Remo ^b   Stevens, David A ^a,c,d  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SAN FRANCISCO STATE UNIVERSITY   (United States)

^c SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticryptococcal activity; Cryptococcus neoformans; Human serum protein

Indexed keywords

ANTIFUNGAL AGENT; PLASMA PROTEIN;

ARTICLE; CHEMISTRY; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; DRUG EFFECT; GEL CHROMATOGRAPHY; GROWTH, DEVELOPMENT AND AGING; HUMAN; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ANTIFUNGAL AGENTS; BLOOD PROTEINS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS;

EID: 0032465099     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006905010363     Document Type: Article

References (10)

1. Stevens DA. Fungal infections in AIDS patients. Brit J Clin Pract 1990; 44: 11-22.
2. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993; 17: 837-842.
3. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100 years after the discovery of Crytococcus neoformans. Clin Microbiol Rev 1995; 8: 515-548.
4. Howard DH. Some factors which affect the initiation of growth of Cryptococcus neoformans. J Bacteriol 1961; 82: 340-345.
5. Baum GL, Artis D. Characterization of the growth inhibition factor for Cryptococcus neoformans in human serum. Am J Med 1963; 87: 53-57.
6. Szilagyi F, Reiss F, Smith JC. The anticryptococcal factor of blood serum. J Invest Dermatol 1966; 46: 306-308.
7. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Polin phenol reagent. J Biol Chem 1951; 193: 265-275.
8. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
9. Nassar F, Brummer E, Stevens DA. Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhanced fluconazole activity. Antimicrob Agents Chemother 1995; 39: 2490-2493.
10. Gadebush HH. Anticryptococcal serum factors in malignant reticuloendothelioses in man. Antimicrob Agents Chemother 1964; 4: 640-648.